Beckman Coulter расширил возможности диагностики инфекционных заболеваний на анализаторе DxI 9000

Beckman Coulter expands infectious disease serology on the DxI 9000 Immunoassay Analyzer Innovations aim to support earlier infectious disease detection through sensitive and efficient serology testing 2 Sept 2026 Beckman Coulter Diagnostics, a Danaher operating company, is expanding high-sensitivity infectious disease serology testing on the DxI 9000 Immunoassay Analyzer. Infectious disease testing continues to evolve as laboratories respond to rising test volumes and expanding screening recommendations. More than one million curable sexually transmitted infections are acquired every day worldwide among people aged 15 to 49, with most infections remaining asymptomatic. This reinforces the importance of sensitive laboratory testing that can support timely detection and informed clinical decision-making¹. Beckman Coulter’s growing Access infectious disease serology portfolio supports testing for HIV, syphilis, viral hepatitis, and other infectious diseases on the high-throughput DxI 9000 platform. The expanding assay menu is designed to help laboratories respond to changing clinical needs while maintaining efficient immunoassay workflows². A key component is the fourth-generation Access HIV Ag/Ab combo assay, which detects and differentiates HIV-1 p24 antigen and HIV-1/HIV-2 antibodies. Combining antigen and antibody detection supports the identification of both early and established HIV infection, providing laboratories with timely information for subsequent clinical decision-making³. Learn more about Beckman Coulter’s high-sensitivity HIV testing and explore its broader infectious disease diagnostics portfolio. Product availability and regulatory status vary by country. References 1. World Health Organization. Sexually transmitted infections (STIs). Available at: https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-%28stis%29 2. Lemée V, Gréaume S, Gautier J, et al. Performance evaluation of the new Access HIV Ag/Ab combo assay on the DxI 9000 Access Immunoassay Analyzer. Journal of Clinical Virology. 2024;174:105712. 3. Beckman Coulter Diagnostics. High Sensitivity HIV Detection. Available at: https://www.beckmancoulter.com/clinical-studies-and-trends/clinical-studies/high-sensitivity-hiv-1-p24-combo-assay Want the latest science news straight to your inbox? Become a SelectScience member for free today>> Links Tags Frequently asked questions Show frequently asked questions How is Beckman Coulter expanding high-sensitivity infectious disease serology testing on the DxI 9000 Access Immunoassay Analyzer? Beckman Coulter Diagnostics is broadening its Access infectious disease serology portfolio on the high-throughput DxI 9000 Access Immunoassay Analyzer. The expanding assay menu supports high-sensitivity testing for HIV, syphilis, viral hepatitis, and other infectious diseases, helping laboratories manage rising test volumes and evolving screening recommendations while maintaining efficient immunoassay workflows. What infectious diseases are targeted by Beckman Coulter’s Access serology portfolio on the DxI 9000 platform? Beckman Coulter’s Access infectious disease serology portfolio on the DxI 9000 Access Immunoassay Analyzer supports testing for HIV, syphilis, viral hepatitis, and additional infectious diseases. This menu is designed to help clinical laboratories respond to changing clinical needs, rising sexually transmitted infection rates, and expanded screening recommendations with efficient, high-throughput immunoassay workflows. What is the Access HIV Ag/Ab Combo assay and how does it support early HIV detection? The fourth-generation Access HIV Ag/Ab Combo assay on the DxI 9000 Access Immunoassay Analyzer detects and differentiates HIV-1 p24 antigen and HIV-1/HIV-2 antibodies. By combining antigen and antibody detection, the assay supports identification of both early and established HIV infection, providing laboratories with timely information to support subsequent clinical decision-making in HIV diagnostics.